NeoGenomics Board Shake-up: Two Directors Depart, Two New Ones Elected
Ticker: NEO · Form: 8-K · Filed: Jun 24, 2025 · CIK: 1077183
Sentiment: neutral
Topics: board-changes, governance
Related Tickers: NEO
TL;DR
NeoGenomics board sees turnover: Goldsmith & Lamy out, D. Smith & R. Smith in.
AI Summary
On June 19, 2025, NeoGenomics, Inc. filed an 8-K report detailing the departure of two directors, Mark Goldsmith and Robert Lamy, effective June 17, 2025. The company also announced the election of two new directors, David H. Smith and Robert L. W. Smith, to its Board of Directors, effective June 19, 2025. These changes are part of the company's ongoing corporate governance adjustments.
Why It Matters
Changes in board composition can signal shifts in company strategy or governance, potentially impacting investor confidence and future decision-making.
Risk Assessment
Risk Level: medium — Board changes can introduce uncertainty regarding future strategy and leadership stability.
Key Players & Entities
- NeoGenomics, Inc. (company) — Registrant
- Mark Goldsmith (person) — Departing Director
- Robert Lamy (person) — Departing Director
- David H. Smith (person) — Newly Elected Director
- Robert L. W. Smith (person) — Newly Elected Director
- June 19, 2025 (date) — Date of earliest event reported
- June 17, 2025 (date) — Effective date of director departures
FAQ
Who are the directors departing NeoGenomics?
Mark Goldsmith and Robert Lamy are departing NeoGenomics, Inc.
When were the director departures effective?
The departures of Mark Goldsmith and Robert Lamy were effective as of June 17, 2025.
Who are the new directors elected to NeoGenomics' Board?
David H. Smith and Robert L. W. Smith have been elected as new directors.
When were the new directors elected?
David H. Smith and Robert L. W. Smith were elected to the Board of Directors effective June 19, 2025.
What is the exact date of the earliest event reported in this 8-K filing?
The date of the earliest event reported is June 19, 2025.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 24, 2025 by Mark Goldsmith regarding NEOGENOMICS INC (NEO).